Pooled odds ratio (OR) and 95% confidence interval (95% CI) for the association of APOC3 polymorphisms and NAFLD risk were calculated using fixed and random-effects models. Here, APOC3 is linked to metabolic dysfunction-associated steatotic liver disease.